Switzerland's CBD and Medical Cannabis Industry Set to Double
Switzerland's CBD and medical cannabis industry is currently valued at an estimated EUR 75 million, a figure expected to more than double as regulated medical and adult-use cannabis consumption picks up. Since August 2022, Swiss physicians can prescribe medical cannabis to patients without limitations. Switzerland's move toward making adult-use and medical-use cannabis accessible is likely to increase demand, with estimates placing the country's future cannabis production at 20 tonnes.
Currently, local governments can set up pilot projects for adult-use cannabis consisting of up to 5,000 existing cannabis users per project, a move that comes close to de facto legalization of adult-use cannabis. Discussions are underway to fully legalize the adult-use market, which could bring cannabis production close to 180 tonnes over time.
